Iclusig is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Ariad Pharmaceuticals, Inc.. The primary component is Ponatinib Hydrochloride.
Product ID | 76189-534_618b6b2f-ca86-4839-9170-e873e279d592 |
NDC | 76189-534 |
Product Type | Human Prescription Drug |
Proprietary Name | Iclusig |
Generic Name | Ponatinib Hydrochloride |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2012-12-14 |
Marketing End Date | 2020-07-26 |
Marketing Category | NDA / NDA |
Application Number | NDA203469 |
Labeler Name | ARIAD Pharmaceuticals, Inc. |
Substance Name | PONATINIB HYDROCHLORIDE |
Active Ingredient Strength | 45 mg/1 |
Pharm Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
NDC Exclude Flag | N |
Marketing Start Date | 2012-12-14 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA203469 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2012-12-14 |
Marketing End Date | 2020-07-26 |
Marketing Category | NDA |
Application Number | NDA203469 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2012-12-14 |
Marketing End Date | 2020-07-26 |
Ingredient | Strength |
---|---|
PONATINIB HYDROCHLORIDE | 45 mg/1 |
SPL SET ID: | 807f988e-117b-4497-934d-73aa78baac71 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
63020-533 | Iclusig | ponatinib hydrochloride |
63020-534 | Iclusig | ponatinib hydrochloride |
63020-535 | Iclusig | ponatinib hydrochloride |
63020-536 | Iclusig | ponatinib hydrochloride |
76189-533 | Iclusig | ponatinib hydrochloride |
76189-534 | Iclusig | ponatinib hydrochloride |
76189-535 | Iclusig | ponatinib hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ICLUSIG 85254659 4324899 Live/Registered |
ARIAD Pharmaceuticals, Inc. 2011-03-01 |